Our Story

The average wait time is 26 days and 89 days to see specialists who understands side effects from novel life-saving cancer drugs. If you are a cancer patient, this wait time means a delay in treating cancer, a delay in treatment of a side effect and a dreaded consequence like a hospitalization.

WE ASKED "What if drugs that cause side effects are no longer a concern?"

Citrus Oncology is here to solve this concern! Our mission is simple - we want those with cancer to get the best benefit from their treatments while worrying less about adverse events, no matter where they are.

Meet our Founders
Dr. Aabid Shariff
Co-founder, CEO
Dr. Afreen Shariff
Co-founder

Our Strategic Advisors

Susan Dent, MD, FRCPC

Professor & Director of the Cardio-Oncology & Survivorship Programs

Wilmot Cancer Institute, University of Rochester

Lisa Foster, MBA

Former Vice President

UnitedHealthCare

Sanjay Juneja, MD

Vice President

Tempus AI

Lidia Schapira, MD

Medical Oncologist, Professor of Medicine, Stanford University

Director, Stanford's Cancer Survivorship Program

Danielle O'Neill

Vice President

ParetoHealth

Robert Copeland-Halperin, MD, FACC

Cardiology

Assistant Professor of Medicine, Northwell Health

Meenal Kheterpal, MD, MMCi, FAAD

Dermatology

Associate Professor of Medicine, Duke University

Alexa Meara, MD

Rheumatology

Associate Professor of Medicine, Ohio State University

Medical Advisors

Arash Rashidi, MD, FACP, FASN

Nephrology

Associate Professor of Medicine, Case Western Reserve University

Afreen Shariff, MD

Endocrinology

Associate Professor of Medicine, Duke University